Liver ischemia-reperfusion injury (IRI) is a sterile inflammatory process that contributes significantly to graft rejection following liver transplantation. Although SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) is known to preserve genomic stability and restrain inflammation under oxidative stress, its immunoregulatory function in myeloid cells during liver IRI has not been elucidated. This study aimed to investigate the role and mechanism of SETDB1 in regulating macrophage-driven inflammatory responses in liver IRI.
Results:
Myeloid-specific SETDB1 knockout (SETDB1 cKO) mice exhibited exacerbated liver injury, increased infiltration of pro-inflammatory macrophages and neutrophils, and amplified inflammatory responses compared with SETDB1fl/fl controls. Depletion of macrophages alleviated liver damage, reduced neutrophil infiltration and hepatocyte apoptosis, and eliminated the excessive injury observed in SETDB1 cKO mice. Mechanistically, SETDB1 suppressed the expression of purinergic receptor P2X7 (P2RX7). Pharmacological inhibition of P2RX7 with oxidized adenosine triphosphate significantly attenuated liver injury and macrophage infiltration in SETDB1 cKO mice. In vitro assays confirmed that SETDB1 inhibited the P2RX7/Caspase-1/Gasdermin D (GSDMD) pathway in macrophages, thereby limiting pyroptosis and inflammation.
Innovation:
This study identifies SETDB1 as a previously unrecognized regulator of macrophage pyroptosis during liver IRI. By linking epigenetic regulation to suppression of the P2RX7/Caspase-1/GSDMD pathway, our findings provide novel mechanistic insight into how SETDB1 protects against sterile liver inflammation.
Conclusion:
SETDB1 plays a pivotal role in protecting the liver from IRI by restraining macrophage-mediated pyroptosis and inflammation. These findings suggest that targeting the SETDB1/P2RX7/Caspase-1/GSDMD axis may represent a promising therapeutic strategy for mitigating liver IRI and improving transplant outcomes. Antioxid. Redox Signal. 45, 133–148.
AdinolfiE, CapeceM, FranceschiniA, et al.Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res2015;75(4):635–644; doi: 10.1158/0008-5472.Can-14-1259
2.
BamboatZM, BalachandranVP, OcuinLM, et al.Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology2010;51(2):621–632; doi: 10.1002/hep.23365
3.
BaricordiOR, MelchiorriL, AdinolfiE, et al.Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP Receptor. J Biol Chem1999;274(47):33206–33208; doi: 10.1074/jbc.274.47.33206
4.
BartlettR, StokesL, SluyterR. The P2X7 receptor channel: Recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev2014;66(3):638–675; doi: 10.1124/pr.113.008003
5.
BidulaS, DhunaK, HelliwellR, et al.Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis2019;10(12):882; doi: 10.1038/s41419-019-2110-3
6.
CharrasA, HofmannSR, CoxA, et al.P2RX7 gene variants associate with altered inflammasome assembly and reduced pyroptosis in chronic nonbacterial osteomyelitis (CNO). J Autoimmun2024;144:103183; doi: 10.1016/j.jaut.2024.103183
7.
ChenL, DaiM, ZuoW, et al.NF-κB p65 and SETDB1 expedite lipopolysaccharide-induced intestinal inflammation in mice by inducing IRF7/NLR-dependent macrophage M1 polarization. Int Immunopharmacol2023;115:109554; doi: 10.1016/j.intimp.2022.109554
8.
CollettiLM, RemickDG, BurtchGD, et al.Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest1990;85(6):1936–1943; doi: 10.1172/jci114656
9.
CsókaB, NémethZH, TörőG, et al.Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. Faseb J2015;29(9):3626–3637; doi: 10.1096/fj.15-272450
10.
Di VirgilioF, Dal BenD, SartiAC, et al.The P2X7 receptor in infection and inflammation. Immunity2017;47(1):15–31; doi: 10.1016/j.immuni.2017.06.020
11.
Di VirgilioF. Novel data point to a broader mechanism of action of oxidized ATP: The P2X7 receptor is not the only target. Br J Pharmacol2003;140(3):441–443; doi: 10.1038/sj.bjp.0705469
12.
DongZ, WeiH, SunR, et al.The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol2007;4(4):241–252.
13.
EamesHL, SalibaDG, KrausgruberT, et al.KAP1/TRIM28: An inhibitor of IRF5 function in inflammatory macrophages. Immunobiology2012;217(12):1315–1324; doi: 10.1016/j.imbio.2012.07.026
14.
GeorgeJ, LuY, TsuchishimaM, et al.Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches. Redox Biol2024;75:103258; doi: 10.1016/j.redox.2024.103258
15.
GriffinGK, WuJ, Iracheta-VellveA, et al.Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. Nature2021;595(7866):309–314; doi: 10.1038/s41586-021-03520-4
16.
HachiyaR, ShiihashiT, ShirakawaI, et al.The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages. Sci Rep2016;6:28845; doi: 10.1038/srep28845
17.
HeS, OwenDR, JelinskySA, et al.Lysine methyltransferase SETD7 (SET7/9) regulates ROS signaling through mitochondria and NFE2L2/ARE pathway. Sci Rep2015;5:14368; doi: 10.1038/srep14368
18.
JiaY, CuiR, WangC, et al.Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway. Redox Biol2020;32:101534; doi: 10.1016/j.redox.2020.101534
JužnićL, PeukerK, StrigliA, et al.SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation. Gut2021;70(3):485–498; doi: 10.1136/gutjnl-2020-321339
21.
KatoA, GabayC, OkayaT, et al.Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol2002;161(5):1797–1803; doi: 10.1016/s0002-9440(10)64456-2
22.
KolachalaVL, LopezC, ShenM, et al.Ischemia reperfusion injury induces pyroptosis and mediates injury in steatotic liver thorough Caspase 1 activation. Apoptosis2021;26(5–6):361–370; doi: 10.1007/s10495-021-01673-1
23.
LiX, QuanP, SiY, et al.The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress. J Neuroinflammation2024;21(1):13; doi: 10.1186/s12974-023-03009-z
24.
LuoL, LiuM, FanY, et al.Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice. J Neuroinflammation2022;19(1):141; doi: 10.1186/s12974-022-02501-2
25.
Muñoz-PlanilloR, KuffaP, Martínez-ColónG, et al.K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity2013;38(6):1142–1153; doi: 10.1016/j.immuni.2013.05.016
26.
OusingsawatJ, WanitchakoolP, KmitA, et al.Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages. Nat Commun2015;6(1):6245; doi: 10.1038/ncomms7245
27.
ParkS, ChoJH, KimJH, et al.Hypoxia stabilizes SETDB1 to maintain genome stability. Nucleic Acids Res2023;51(20):11178–11196; doi: 10.1093/nar/gkad796
28.
PeraltaC, Jiménez-CastroMB, Gracia-SanchoJ. Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu. J Hepatol2013;59(5):1094–1106; doi: 10.1016/j.jhep.2013.06.017
29.
QianY, QianC, XieK, et al.P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury. Cell Death Dis2021;12(1):132; doi: 10.1038/s41419-020-03384-y
30.
RobinsonN, GanesanR, HegedűsC, et al.Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos. Redox Biol2019;26:101239; doi: 10.1016/j.redox.2019.101239
31.
RoohaniS, TackeF. Liver injury and the macrophage issue: Molecular and mechanistic facts and their clinical relevance. Int J Mol Sci2021;22(14):7249; doi: 10.3390/ijms22147249
32.
SavioLEB, de Andrade MelloP, da SilvaCG, et al.The P2X7 receptor in inflammatory diseases: Angel or demon? Front Pharmacol2018;9:52; doi: 10.3389/fphar.2018.00052
33.
SchultzDC, AyyanathanK, NegorevD, et al.SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev2002;16(8):919–932; doi: 10.1101/gad.973302
34.
StrepkosD, MarkouliM, KlonouA, et al.Histone methyltransferase SETDB1: A common denominator of tumorigenesis with therapeutic potential. Cancer Res2021;81(3):525–534; doi: 10.1158/0008-5472.Can-20-2906
35.
SurprenantA, RassendrenF, KawashimaE, et al.The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science1996;272(5262):735–738; doi: 10.1126/science.272.5262.735
36.
van GolenRF, van GulikTM, HegerM. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev2012;23(3):69–84; doi: 10.1016/j.cytogfr.2012.04.006
37.
WalevI, ReskeK, PalmerM, et al.Potassium-inhibited processing of IL-1 beta in human monocytes. Embo J1995;14(8):1607–1614; doi: 10.1002/j.1460-2075.1995.tb07149.x
38.
WangH, XiZ, DengL, et al.Macrophage polarization and liver ischemia-reperfusion injury. Int J Med Sci2021;18(5):1104–1113; doi: 10.7150/ijms.52691
39.
WangR, LiH, WuJ, et al.Gut stem cell necroptosis by genome instability triggers bowel inflammation. Nature2020;580(7803):386–390; doi: 10.1038/s41586-020-2127-x
40.
WangS, ChenY, HanS, et al.Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway. Theranostics2022;12(8):3882–3895; doi: 10.7150/thno.70830
41.
XiaK, HuiY, ZhangL, et al.SETDB1 targeting SESN2 regulates mitochondrial damage and oxidative stress in renal ischemia-reperfusion injury. BMC Biol2024;22(1):246; doi: 10.1186/s12915-024-02048-z
42.
XiaK, WangT, ChenZ, et al.Hepatocellular SETDB1 regulates hepatic ischemia-reperfusion injury through targeting lysine methylation of ASK1 signal. Research (Wash D C)2023;6:0256; doi: 10.34133/research.0256
43.
YanWT, ZhaoWJ, HuXM, et al.PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons. Neural Regen Res2023;18(2):357–363; doi: 10.4103/1673-5374.346545
44.
YanpisetP, ManeechoteC, SriwichaiinS, et al.Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies. Acta Pharm Sin B2023;13(1):29–53; doi: 10.1016/j.apsb.2022.08.007
45.
ZhangSM, CaiWL, LiuX, et al.KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature2021;598(7882):682–687; doi: 10.1038/s41586-021-03994-2
46.
ZhouH, WangH, NiM, et al.Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation. J Hepatol2018;69(1):99–109; doi: 10.1016/j.jhep.2018.01.036
